Drawing for RFS

USPTO serial 98700128

RFS

Reviewed by CopyMark Law Group

Reg. 8132234Status 700Registered
Filing date
Status date
Registration date
Feb 10, 2026
Examiner
CHOSID, ROBIN S
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RFS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

B. Anna McCoy

B. Anna McCoy McCoy Russell LLP1410 NW Johnson St.Suite 201Portland, OR 97209

Goods and services

ClassDescriptionStatusFirst use
005Biological coronary artery bypass grafts; Surgical implants comprising living tissue; Biological tissue implants; Implants for guided tissue regeneration comprised of biological materials; Implantable biological materials for use in guided tissue regeneration; Implantable biological textile material to encourage the growth of tissue; Arterial grafts; Vascular grafts comprised of living tissue; Skin grafts; Adhesive patches for medical purposes; Transdermal patches featuring cardiovascular medications for medical treatment; Tissue-regenerative pharmaceutical preparations; Living tissues for medical use intended for subsequent implantation; Tissues for surgical use, namely, surgical implants comprised of living tissues; Live organs and tissues for surgical implanting purposes; Wound closures, namely, adhesive for bandages for skin woundsACTIVE—
010Angioplasty catheters; Angioplasty balloon catheters; Angiographic vascular introducers for the placement of catheters; Balloon angioplasty inflation instruments; Balloon angioplasty inflation apparatus; Balloon catheters; Balloon inflating devices for balloon dilation catheters; Calibration catheters; Cannulae; Cardiac catheters; Cardiac vascular prosthesis for surgical protheses; Cardiovascular instruments, namely, medical instruments for use in cardiovascular procedures; Catheter apparatus for gastroenterological use; Catheter sets; Catheters; Catheters for medical use; Catheters for surgical use; Catheters for urological purposes; Catheters for use in urology; Catheters for use in embolectomy; Catheters incorporating filters; Central venous catheters; Cervical balloon catheters; Cervical portio adapters; Chest drainage devices for removal of fluids from the pleural cavity of patients; Coronary balloon dilatation catheters for angioplasty; Dilatation catheters; Embolic devices for treating anomalies vasculature of the body; Endotracheal tubes; Expandable braids comprising artificial material for insertion in tubular organs of the body for the treatment of stenosis; Expandable braids comprising artificial material for insertion in oesophagus for the treatment of stenosis; Expandable braids comprising artificial material for insertion in blood vessels for treating stenosis; Expandable braids comprising artificial material for insertion in bile ducts for treating stenosis; Filters for use within veins, namely, implantable blood filters made of artificial materials; Implantable filters made of artificial materials for temporary placement within veins; Medical guide wires for use with balloon dilation catheters; Medical guide wires for use with balloon dilatation catheters; Medical guide wires; Injection sleeves for medical use for delivering medications into the sheath surrounding a nerve root; Inner lumens for balloon catheters; Medical instruments for intraluminar sclerosation of varicose veins; Intracardiac catheter; Intramedullary plugs; Intravenous catheter sets; Intravenous catheters; Medical instruments for use in gastrointestinal surgery; Medical instruments, namely, introducers for implanting vena-cava filters; Medical instruments, namely, introducers for implanting anti-embolic filters; Medical and surgical catheters; Medical apparatus for urethral catheterization; Medical apparatus for use in cardiac surgery; Medical apparatus for use in endoscopy; Medical catheters; Medical devices for placing and securing catheters; Medical guide wires; Medical tubing for transfusions; Synthetic mesh nerve connecting tubes for medical use; Protective guards for catheters; Shunts made of artificial materials for use in the blood circulatory system; Medical instruments for surgical bypass devices; Surgical mesh comprised primarily of artificial materials; Tubing for use with catheters; Tubing for use with cannulas; Tubes for veterinary use; Urethral catheterization instruments; Urethral catheters; Venous catheters for human use; Vascular access ports for medical use; Medical devices for closing wounds; Medical stents; Implantable urethral stents; Ureteral stents being surgical support; Biocompatible coated stents; Stents; Surgical apparatus and instruments for medical use; Artificial surgical implants; Surgical implants comprised of artificial materials; Surgical implants made of artificial materials; Prosthetic implants comprised of artificial materials; Biodegradable vascular implants; Artificial vascular implants; Prosthesis, namely, implants made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies; Medical implants, namely, intravascular implants comprised of artificial materials; Artificial organs for implantation; Prosthetics and artificial implants, namely, tissues for vascular use; Subcutaneous valves comprised of artificial materials for implantation; Implants consisting of artificial materials; Medical implants made of artificial materials; Medical devices, namely, intravascular implants comprised of artificial material; Subcutaneous valves comprised of artificial materials for implantation; Artificial vascular grafts; Grafts for surgical use made primarily of artificial materials for coronary artery bypass surgery; Medical devices, namely, endovascular medical devices; Medical and veterinary surgical apparatus and instruments; Sutures; Medical devices, namely, suture and wound closing materials and instruments; Prosthetic tissues for vascular useACTIVE—
042Tissue engineering; Science and technology services, namely, development of medical stents; Medical and pharmacological research services; Engineering services; Testing, authentication and quality control of the goods of others in the medical field; Medical research services; Quality control for others; Testing of materialsACTIVE—
044Medical care; Medical treatment services, namely, medical treatment of atherosclerosis and cardiovascular diseases; Medical services; Veterinary services, namely, professional consultancy in the field of veterinary medicine; Veterinary surgery; Veterinary services; Hygienic and beauty care for animals; Hygienic and beauty care for human beings; Pharmacy advice in the nature of pharmaceutical consultancy; Medical assistance; Hospital services; Health care; Health care services; Health center services; Medical clinic services; Telemedicine services; Therapy services, namely, physical therapy; Medical equipment rentalACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 10, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 10, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 23, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 23, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 17, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 2, 2025PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Aug 4, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 3, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 3, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 3, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 19, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
May 19, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Feb 22, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 20, 2025DOCKASSIGNED TO EXAMINER—
Jan 17, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 15, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance